Multiple manufacturers receive FDA approval for generic dapagliflozin to treat type 2 diabetes and lower heart failure risks in high-risk T2D patients.

A study of 132,000 children finds that high BMI in mid- to late childhood is the strongest predictor of early pubertal onset.

Researchers identify an optimal visceral adipose tissue range of 46.5-116.6 cm² to minimize the combined risk of diabetes and osteoporosis.

Ixekizumab (IXE) plus tirzepatide shows significant benefits for outcomes in PsA vs IXE alone in adults with overweight or obesity.

For adults aged 65 years and older, the risk for incident AD is lower for those who receive a high versus standard dose of IIV.

The AHA released new nutrition guidance recommending plant-based proteins like beans, lentils and nuts instead of red and processed meats.

A study of 11 high-income jurisdictions reveals that CVD is no longer the leading cause of death for people with diabetes in many regions.

Cognitive behavioral therapy (CBT) significantly reduces BMI z-scores and improves quality of life among children with obesity.

Black adults with high BP who receive dietitian counseling and follow the DASH diet experience improvements in BP at 3 months.

Use of tirzepatide, compared with dulaglutide, is associated with a 20% lower risk for MACE among patients with T2D and ASCVD.

Two chocolate products marketed for sexual enhancement are being recalled because of hidden prescription drug ingredients.

The US Centers for Disease Control and Prevention (CDC) has paused more than two dozen types of lab tests for "a routine review." ...